Cytori Therapeutics (CYTX) Outcomes at 18 Months in Cardiac Cell Therapy Heart Attack Trial
June 8th, 2011
No comments
CYTX reported 18 month outcomes from its APOLLO trial for Acute Myocardial Infarction (AMI). Read more…
Categories: 18 month outcomes from its APOLLO trial, NASDAQ: CYTX
